Chattem putting a new face on pHisoDerm with $6 mil. TV ad campaign.
This article was originally published in The Tan Sheet
Executive SummaryCHATTEM BACKING PHISODERM RELAUNCH WITH $6 MIL. in TV ad spending for July through November, according to the company. The 15- and 30-second national television spots will highlight updates to the skin cleansing and conditioning line such as reformulation and repackaging. The relaunch follows Chattem's acquisition of marketing rights to pHisoDerm in the U.S., Canada and Puerto Rico from Sterling Winthrop in June 1994 ("The Tan Sheet" June 27, 1994, p. 7)
You may also be interested in...
Abbott is encouraged by results from two studies of its Proclaim XR neurostimulation system for chronic pain, presented at the annual North American Neuromodulation Society (NANS) meeting in Las Vegas. See what Steven Falowski of Neurosurgical Associates of Lancester in Pennsylvania said about it here.
While disappointing result will probably put an end to single-drug plans in ovarian cancer, the blockbuster anti-PD-1 immunotherapy remains in combination development for the indication.
According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.